- Home
- BOF vs IGC Comparison
BOF vs IGC Comparison
Compare BOF & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- IGC
- Stock Information
- Founded
- BOF 2017
- IGC 2005
- Country
- BOF United States
- IGC United States
- Employees
- BOF N/A
- IGC N/A
- Industry
- BOF Packaged Foods
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- IGC Health Care
- Exchange
- BOF Nasdaq
- IGC Nasdaq
- Market Cap
- BOF 16.7M
- IGC 19.1M
- IPO Year
- BOF 2023
- IGC N/A
- Fundamental
- Price
- BOF $2.41
- IGC $0.28
- Analyst Decision
- BOF
- IGC Strong Buy
- Analyst Count
- BOF 0
- IGC 2
- Target Price
- BOF N/A
- IGC $3.88
- AVG Volume (30 Days)
- BOF 185.5K
- IGC 415.4K
- Earning Date
- BOF 05-13-2025
- IGC 02-18-2025
- Dividend Yield
- BOF N/A
- IGC N/A
- EPS Growth
- BOF N/A
- IGC N/A
- EPS
- BOF N/A
- IGC N/A
- Revenue
- BOF $6,489,951.00
- IGC $1,236,000.00
- Revenue This Year
- BOF N/A
- IGC N/A
- Revenue Next Year
- BOF N/A
- IGC $18.34
- P/E Ratio
- BOF N/A
- IGC N/A
- Revenue Growth
- BOF 372.36
- IGC 1.65
- 52 Week Low
- BOF $0.61
- IGC $0.26
- 52 Week High
- BOF $4.11
- IGC $0.91
- Technical
- Relative Strength Index (RSI)
- BOF 57.91
- IGC 40.22
- Support Level
- BOF $2.09
- IGC $0.29
- Resistance Level
- BOF $2.82
- IGC $0.30
- Average True Range (ATR)
- BOF 0.23
- IGC 0.02
- MACD
- BOF 0.04
- IGC -0.00
- Stochastic Oscillator
- BOF 59.80
- IGC 4.00
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.